AUSTIN, Texas and TOKYO, Sept. 16, 2025 /PRNewswire/ -- According to the DataM Intelligence: The global digital therapeutics market size reached US$ 6.84 Billion in 2024 and is expected to reach US$ 39.52 Billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033.
Digital therapeutics (DTx) are software-based interventions designed to assist both healthcare professionals and patients in managing and treating a variety of conditions ranging from mental health and chronic diseases to neurological disorders, addiction recovery, and rehabilitation. These tools often provide personalized care through techniques like cognitive behavioral therapy, symptom tracking, and virtual exercises, targeting ailments such as diabetes, depression, substance use disorders, and physical injury recovery.
Researchers from the University of Auckland highlight that for digital-native companies, commercialization and international expansion are intertwined from the start. Unlike traditional healthcare firms that expand internationally only after domestic success, digital therapeutics companies face a global market immediately, requiring them to embed global strategies early on. They must adapt to diverse regulatory and reimbursement systems, tailoring product design and business models to different socio-political and economic conditions.
The global digital therapeutics market now demands that commercialization and international growth proceed simultaneously. Companies must balance innovation with compliance, reimbursement integration, and scalability across various healthcare ecosystems to succeed in a complex, competitive global environment.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response):https://www.datamintelligence.com/download-sample/digital-therapeutics-market
By Product Type: Software Leads the Market with 45.5% Share in 2024
Software leads the digital therapeutics market due to its scalability, low cost, and accessibility on devices like smartphones and browsers. It enables personalized coaching, AI-driven therapy, and digital cognitive behavioral treatments without physical devices. Faster regulatory approval for software as a medical device (SaMD) accelerates market entry. Patients and providers prefer software for its affordability, ease of updates, and versatile applications.
By Application: Diabetes Management Tops the Segment with 35.3% Share in 2024
Diabetes management drives digital therapeutics growth, with over 589 million affected globally in 2024. Digital tools like apps, wearables, and AI platforms support continuous monitoring, behavior change, and treatment adherence. Leading platforms such as Livongo and Omada Health have shown improved outcomes, and in April 2025, Q4 Inc. received FDA clearance for its Continuous Glucose Monitoring System for adults with diabetes.
Get Customization in the report as per your business requirements: https://www.datamintelligence.com/customize/digital-therapeutics-market
North America Dominates the Global Digital Therapeutics Market with 43.3% Share in 2024
North America leads the global digital therapeutics market, driven by advanced digital infrastructure, a high prevalence of chronic conditions like diabetes and heart disease, and a mature healthcare system. In the U.S., FDA approvals and insurance coverage boost adoption, while major companies such as Livongo (Teladoc), Omada Health, and Akili Interactive benefit from strong funding and support.
Europe Holds Strong Position as Second-Largest Region with 33.4% Share in 2025
Europe follows North America with strong regulations and public support driving growth. Germany's DiGA program allows insurance reimbursement for prescribed digital therapies, and countries like the UK, France, and Nordic nations integrate digital solutions into healthcare. An aging population and rising chronic diseases boost demand for scalable, cost-effective care.
Asia Pacific Emerges as Fastest-Growing Region with 9.9% CAGR in 2024
The Asia Pacific region leads global digital therapeutics growth due to its large population, rising chronic diseases, and strong policy support. Countries like China, India, and Japan invest heavily in telehealth, AI, and digital infrastructure. High mobile and internet access combined with increasing healthcare costs drive demand for affordable, efficient digital health solutions.
Key Digital Therapeutics Market Companies
The major market players in the digital therapeutics market are Digital Therapeutics Alliance, Noom, Inc., Omada Health, Inc., Q4, Inc., Teladoc Health, Inc., Akili, Inc., Kaia Health, Welldoc, Inc., Hinge Health, Inc., and Click Therapeutics, Inc., among others.
Purchase This Exclusive Report at Just USD 4350 Only: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-market
Recent Developments:
- In March 2024, The FDA in the United States approved Click Therapeutics, Inc.'s Rejoyn, the first prescription digital therapy (a smartphone app) to treat symptoms of severe depressive illness. It is intended to address the symptoms of depression in a manner distinct from those of medicine. It uses brief skills-based treatment sessions and tried-and-true brain-training exercises to harness the brain's innate capacity for change.
- In March 2025, Digital Therapeutics Alliance (DTA) was acquired by American Telemedicine Association (ATA). Digital Therapeutics Alliance was dedicated to increasing access to digital therapies (DTx) is DTA. Together, the two organizations build a powerful platform for lobbying and policy, concentrating on developing cutting-edge technologies that are revolutionizing patient care.
Related Reports:
Remote Patient Monitoring Market Size, Share, Growth Trends & Forecast (2024-2031)
Generative AI in Healthcare Market Size, Share Analysis, Growth Trends & Report 2025-2033
Personalized Medicine Market Size, Share, Industry, Forecast and outlook (2024-2031)
About DataM Intelligence 4Market Research:
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Content Source: https://www.datamintelligence.com/research-report/digital-therapeutics-market
Visit Our Website: https://www.datamintelligence.com
Logo - https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/digital-therapeutics-market-to-surpass-us-39-52-billion-by-2033--with-a-21-6-cagr-growth-report-by-datam-intelligence-302558067.html
